News

December 14, 2018December 14, 2018

ALS Patients’ Sexuality, Intimacy Issues Should Be Addressed by Healthcare Pros, Study Suggests

News

Sexuality and intimacy are important aspects of one’s life that are also affected by amyotrophic lateral sclerosis (ALS), according to a review study. It is important that clinicians and ... Read more

December 13, 2018December 13, 2018

Anticonvulsant Potiga Lowers Motor Neuron Excitability in ALS Patients, Phase 2 Trial Shows

News

Treatment with the anticonvulsant Potiga (ezogabine) lessened abnormal motor neuron excitability, or responsiveness, in patients with amyotrophic lateral sclerosis (ALS), according to top-line results of a Phase 2 clinical ... Read more

December 12, 2018December 12, 2018

Device That Reproduces Food Flavors May Benefit ALS Patients, Study Reports

News

Amyotrophic lateral sclerosis (ALS) patients with impaired swallowing show loss of taste perception, according to a new study. This problem is greater in patients requiring a feeding tube. The ... Read more

December 11, 2018December 11, 2018

$2.5M Awarded to Investigate Mechanisms Linking Neurodegenerative Diseases to Infections

News

A new research project that will investigate the seemingly unrelated mechanisms between neurodegenerative diseases and infections has been awarded $2.5 million from the Chan Zuckerberg Initiative (CZI). The funding was ... Read more

December 10, 2018December 10, 2018

Graphene May be Used to Detect Biomarkers for ALS, Study Reports

News

Graphene, a material made up of a thin sheet of carbon, may be used in the future to detect and measure biomarkers able to identify patients with amyotrophic lateral ... Read more

December 7, 2018December 7, 2018

Biogen Acquires Full Rights to Develop, Market BIIB067 as Potential Treatment for ALS

News

Biogen has decided to exercise its option to acquire from Ionis Pharmaceuticals the exclusive rights to develop and commercialize BIIB067 as a potential treatment for amyotrophic lateral sclerosis (ALS). The decision ... Read more

December 6, 2018December 6, 2018

Affiliated Managers Group Gives $20M to Help Establish ALS Research Center

News

Global asset management company Affiliated Managers Group (AMG) has announced a $20 million matching gift to establish the Healey Center at Massachusetts General Hospital, the goal of which is to ... Read more

December 5, 2018December 5, 2018

Strategies to Cope with ALS Need to Address Depression and Anxiety Together, Study Says

News

Depression and anxiety in amyotrophic lateral sclerosis (ALS) patients, even at low levels, are linked and should be addressed together, a study reports. Moreover, according to the study, support to caregivers ... Read more

December 4, 2018December 4, 2018

Fruit Compound Called Resveratrol May Strengthen Abilities of Stems Cells of ALS Patients

News

A natural compound found in certain fruits and vegetables, called resveratrol, may help boost the ability of mesenchymal stem cells taken from amyotrophic lateral sclerosis (ALS) patients to transform into ... Read more

December 3, 2018

First Human Trial for ALS Treatment Candidate AT-1501 Begins Dosing

News

Anelixis Therapeutics has begun dosing patients in the first human trial of its amyotrophic lateral sclerosis (ALS) treatment candidate, AT-1501, the company announced. The trial is currently enrolling both healthy volunteers ... Read more

Pin It on Pinterest